Latest Insider Transactions at Exact Sciences Corp (EXAS)
This section provides a real-time view of insider transactions for Exact Sciences Corp (EXAS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXACT SCIENCES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXACT SCIENCES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,230
-4.79%
|
$587,970
$139.36 P/Share
|
|
Mar 02
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
2,524
-5.26%
|
$348,312
$138.42 P/Share
|
|
Mar 01
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
3,525
+4.45%
|
-
|
|
Mar 01
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,575
+2.48%
|
-
|
|
Mar 01
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+37.44%
|
$202,400
$22.18 P/Share
|
|
Mar 01
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+10.0%
|
-
|
|
Mar 01
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+9.47%
|
-
|
|
Mar 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
31,293
-1.92%
|
$4,287,141
$137.11 P/Share
|
|
Mar 01
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
5,673
-45.24%
|
$777,201
$137.11 P/Share
|
|
Mar 01
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,098
-1.5%
|
$150,426
$137.44 P/Share
|
|
Mar 01
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,403
-8.88%
|
$1,151,211
$137.11 P/Share
|
|
Mar 01
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
1,603
-3.59%
|
$219,611
$137.44 P/Share
|
|
Feb 26
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,312
+1.12%
|
-
|
|
Feb 26
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
3,263
+41.69%
|
-
|
|
Feb 26
2021
|
James Edward Doyle |
SELL
Open market or private sale
|
Direct |
2,000
-6.16%
|
$260,000
$130.11 P/Share
|
|
Feb 26
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,357
+3.12%
|
-
|
|
Feb 26
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,437
+6.6%
|
-
|
|
Feb 26
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,263
+6.82%
|
-
|
|
Feb 26
2021
|
Michael S Wyzga Director |
SELL
Open market or private sale
|
Direct |
19,021
-88.15%
|
$2,472,730
$130.11 P/Share
|
|
Feb 26
2021
|
Michael S Wyzga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,108
+31.9%
|
$262,808
$26.98 P/Share
|
|
Feb 25
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
6,788
-83.92%
|
$896,016
$132.96 P/Share
|
|
Feb 24
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
2,057
-2.82%
|
$279,752
$136.3 P/Share
|
|
Feb 24
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
16,420
-1.99%
|
$2,233,120
$136.3 P/Share
|
|
Feb 24
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
6,062
-42.84%
|
$824,432
$136.3 P/Share
|
|
Feb 24
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,449
-8.97%
|
$605,064
$136.3 P/Share
|
|
Feb 24
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
5,842
-12.38%
|
$794,512
$136.3 P/Share
|
|
Feb 23
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+5.56%
|
-
|
|
Feb 23
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,325
+3.99%
|
-
|
|
Feb 23
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
18,750
-56.99%
|
$2,550,000
$136.51 P/Share
|
|
Feb 23
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
31,600
+41.95%
|
$316,000
$10.84 P/Share
|
|
Feb 23
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,300
+15.79%
|
-
|
|
Feb 23
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+19.7%
|
-
|
|
Feb 19
2021
|
Jacob A Orville EVP, GM, Screening |
SELL
Open market or private sale
|
Direct |
1,696
-23.75%
|
$242,528
$143.38 P/Share
|
|
Feb 18
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
1,980
-60.35%
|
$277,200
$140.79 P/Share
|
|
Feb 18
2021
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
3,649
+33.82%
|
-
|
|
Feb 17
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,033
-1.48%
|
$146,686
$142.66 P/Share
|
|
Feb 17
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
15,825
-1.96%
|
$2,247,150
$142.66 P/Share
|
|
Feb 17
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
1,992
-37.78%
|
$282,864
$142.66 P/Share
|
|
Feb 17
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,020
-4.77%
|
$286,840
$142.66 P/Share
|
|
Feb 17
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
2,131
-5.65%
|
$302,602
$142.66 P/Share
|
|
Feb 17
2021
|
Jacob A Orville EVP, GM, Screening |
SELL
Open market or private sale
|
Direct |
1,033
-22.83%
|
$146,686
$142.66 P/Share
|
|
Feb 16
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+2.83%
|
-
|
|
Feb 16
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,132
+3.71%
|
-
|
|
Feb 16
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+42.96%
|
-
|
|
Feb 16
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+8.58%
|
-
|
|
Feb 16
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+9.53%
|
-
|
|
Feb 16
2021
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+30.97%
|
-
|
|
Feb 05
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,543
+2.21%
|
$87,715
$5.7 P/Share
|
|
Feb 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
30,344
-3.84%
|
$4,187,472
$138.07 P/Share
|
|
Jan 04
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
31,814
-3.71%
|
$4,072,192
$128.74 P/Share
|